MRI-based navigated cryosurgery of extra-abdominal desmoid tumors using skin fiducial markers: a case series of 15 cases.
3D planning
Desmoid Tumor
Fiducial markers
MRI-based navigation
Percutaneous CRA
Journal
BMC musculoskeletal disorders
ISSN: 1471-2474
Titre abrégé: BMC Musculoskelet Disord
Pays: England
ID NLM: 100968565
Informations de publication
Date de publication:
15 Dec 2023
15 Dec 2023
Historique:
received:
13
08
2022
accepted:
28
11
2023
medline:
16
12
2023
pubmed:
16
12
2023
entrez:
15
12
2023
Statut:
epublish
Résumé
Precision surgery is becoming increasingly important in the field of Orthopaedic Oncology. Image-guided percutaneous cryosurgery (CRA) has emerged as a valid treatment modality for extra-abdominal desmoid tumors (EDTs). To date, most CRA procedures use CT-based guidance which fails to properly characterize tumor segments. Computer-guided MRI navigation can address this issue however, the lack of a fixed landmark for registration remains a challenge. Successful CRA correlates directly with precision approaches facilitated by intraoperative imaging guidance. This is the first study that attempts to assess the feasibility and efficacy of a novel approach of using skin fiducial markers to overcome the challenge of a MRI-based navigation CRA for symptomatic or progressive EDTs. In this retrospective study conducted between 2018 and 2020, 11 patients at a single center with symptomatic or progressive EDTs were treated with CRA using intraoperative MRI navigation. Fifteen cryosurgery procedures were performed, each adhering to a personalized pre-operative plan. Total tumor size, viable and non-viable portions pre- and post-operation, and SF-36 questionnaire evaluating subjective health were recorded. All CRAs demonstrated 100% adherence to the predetermined plan. Overall, tumor size decreased Median= -56.9% [-25.6, -72.4]) with a reduction in viable tissue, (Median= -80.4% [-53.3, -95.2]). Four patients required additional CRAs. Only one patient's tumor did not reduce in size. One patient suffered from local muscle necrosis. Pre-operation, the average physical and mental scores 41.6 [29.4, 43] and 26.3 [17.6, 40.9] respectively. Post-operation, the average physical and mental scores were 53.4[38, 59.7] and 38 [31.2, 52.7] respectively. These findings provide an early indication of the feasibility and efficacy of performing percutaneous cryosurgery using skin fiducial marker registration for MRI-computed navigation to treat EDTs safely. Larger cohorts and multicenter evaluations are needed to determine the efficacy of this technique.
Sections du résumé
BACKGROUND
BACKGROUND
Precision surgery is becoming increasingly important in the field of Orthopaedic Oncology. Image-guided percutaneous cryosurgery (CRA) has emerged as a valid treatment modality for extra-abdominal desmoid tumors (EDTs). To date, most CRA procedures use CT-based guidance which fails to properly characterize tumor segments. Computer-guided MRI navigation can address this issue however, the lack of a fixed landmark for registration remains a challenge. Successful CRA correlates directly with precision approaches facilitated by intraoperative imaging guidance. This is the first study that attempts to assess the feasibility and efficacy of a novel approach of using skin fiducial markers to overcome the challenge of a MRI-based navigation CRA for symptomatic or progressive EDTs.
METHODS
METHODS
In this retrospective study conducted between 2018 and 2020, 11 patients at a single center with symptomatic or progressive EDTs were treated with CRA using intraoperative MRI navigation. Fifteen cryosurgery procedures were performed, each adhering to a personalized pre-operative plan. Total tumor size, viable and non-viable portions pre- and post-operation, and SF-36 questionnaire evaluating subjective health were recorded.
RESULTS
RESULTS
All CRAs demonstrated 100% adherence to the predetermined plan. Overall, tumor size decreased Median= -56.9% [-25.6, -72.4]) with a reduction in viable tissue, (Median= -80.4% [-53.3, -95.2]). Four patients required additional CRAs. Only one patient's tumor did not reduce in size. One patient suffered from local muscle necrosis. Pre-operation, the average physical and mental scores 41.6 [29.4, 43] and 26.3 [17.6, 40.9] respectively. Post-operation, the average physical and mental scores were 53.4[38, 59.7] and 38 [31.2, 52.7] respectively.
CONCLUSION
CONCLUSIONS
These findings provide an early indication of the feasibility and efficacy of performing percutaneous cryosurgery using skin fiducial marker registration for MRI-computed navigation to treat EDTs safely. Larger cohorts and multicenter evaluations are needed to determine the efficacy of this technique.
Identifiants
pubmed: 38102608
doi: 10.1186/s12891-023-07074-6
pii: 10.1186/s12891-023-07074-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
969Informations de copyright
© 2023. The Author(s).
Références
Sakorafas GH, Nissotakis C, Peros G. Abdominal desmoid tumors. Surg Oncol. 2007;16:131–42. https://doi.org/10.1016/j.suronc.2007.07.009 .
doi: 10.1016/j.suronc.2007.07.009
pubmed: 17719772
Lewis JJ, Boland PJ, Leung DH, Woodruff JM, Brennan MF. The enigma of desmoid tumors. Ann Surg. 1999;229:863–6. https://doi.org/10.1097/00000658-199906000-00014 .
doi: 10.1097/00000658-199906000-00014
Mankin HJ, Hornicek FJ, Springfield DS. Extra-abdominal desmoid tumors: a report of 234 cases. J Surg Oncol. 2010;102:380–4. https://doi.org/10.1002/jso.21433 .
doi: 10.1002/jso.21433
pubmed: 19877160
Cuomo P, Scoccianti G, Schiavo A, Tortolini V, Wigley C, Muratori F, et al. Extra-abdominal desmoid Tumor fibromatosis: a multicenter EMSOS study. BMC Cancer. 2021;21:437. https://doi.org/10.1186/s12885-021-08189-6 .
doi: 10.1186/s12885-021-08189-6
pubmed: 33879110
pmcid: 8059004
Seinen JM, Niebling MG, Bastiaannet E, Pras B, Hoekstra HJ. Four different treatment strategies in aggressive fibromatosis: a systematic review. Clin Transl Radiat Oncol. 2018;12:1–7. https://doi.org/10.1016/j.ctro.2018.03.001 .
doi: 10.1016/j.ctro.2018.03.001
pubmed: 30069502
pmcid: 6067057
Salas S, Dufresne A, Bui B, Blay J-Y, Terrier P, Ranchere-Vince D, et al. Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to Tumor presentation. J Clin Oncology: Official J Am Soc Clin Oncol. 2011;29:3553–8. https://doi.org/10.1200/JCO.2010.33.5489 .
doi: 10.1200/JCO.2010.33.5489
Fiore M, Rimareix F, Mariani L, Domont J, Collini P, Le Péchoux C, et al. Desmoid-type fibromatosis: a front-line Conservative approach to select patients for surgical treatment. Ann Surg Oncol. 2009;16:2587–93. https://doi.org/10.1245/s10434-009-0586-2 .
doi: 10.1245/s10434-009-0586-2
pubmed: 19568815
von Mehren M, Kane JM, Bui MM, Choy E, Connelly M, Dry S, et al. NCCN guidelines insights: soft tissue sarcoma, Version 1.2021. J Natl Compr Canc Netw. 2020;18:1604–12. https://doi.org/10.6004/jnccn.2020.0058 .
doi: 10.6004/jnccn.2020.0058
Smith K, Desai J, Lazarakis S, Gyorki D. Systematic review of clinical outcomes following various treatment options for patients with Extraabdominal Desmoid tumors. Ann Surg Oncol. 2018;25:1544–54. https://doi.org/10.1245/s10434-018-6408-7 .
doi: 10.1245/s10434-018-6408-7
pubmed: 29644533
Garcia-Ortega DY, Martín-Tellez KS, Cuellar-Hubbe M, Martínez-Said H, Álvarez-Cano A, Brener-Chaoul M, et al. Desmoid-Type Fibromatosis Cancers (Basel). 2020;12. https://doi.org/10.3390/cancers12071851 .
Efrima B, Ovadia J, Drukman I, Khoury A, Rath E, Dadia S et al. Cryo-surgery for symptomatic extra-abdominal desmoids. A proof of concept study. J Surg Oncol 2021;124. https://doi.org/10.1002/jso.26528 .
Redifer Tremblay K, Lea WB, Neilson JC, King DM, Tutton SM. Percutaneous cryoablation for the treatment of extra-abdominal desmoid tumors. J Surg Oncol. 2019;120:366–75. https://doi.org/10.1002/jso.25597 .
doi: 10.1002/jso.25597
pubmed: 31236956
pmcid: 6790665
Kurtz J-E, Buy X, Deschamps F, Sauleau E, Bouhamama A, Toulmonde M, et al. CRYODESMO-O1: a prospective, open phase II study of cryoablation in desmoid tumour patients progressing after medical treatment. Eur J Cancer. 2021;143:78–87. https://doi.org/10.1016/j.ejca.2020.10.035 .
doi: 10.1016/j.ejca.2020.10.035
pubmed: 33290994
Wang M, Li D, Shang X, Wang J. A review of computer-assisted orthopaedic Surgery systems. Int J Med Rob Comput Assist Surg 2020;16. https://doi.org/10.1002/rcs.2118 .
Hernigou J, Morel X, Hernigou P. Computer Navigation Technique for Simultaneous Total Knee Arthroplasty and opening Wedge High Tibial Osteotomy in patients with large tibial Varus deformity. Surg Technol Int. 2020;37:265–74.
pubmed: 33238026
McCulloch RA, Frisoni T, Kurunskal V, Maria Donati D, Jeys L. Computer Navigation and 3D Printing in the Surgical Management of Bone Sarcoma. Cells 2021;10. https://doi.org/10.3390/cells10020195 .
Eccles C, Whitaker J, Nyland J, Roberts C, Carlson J, Zamora R. Skin fiducial markers enable accurate computerized navigation resection of simulated soft tissue tumors: a static cadaveric model pilot study. J Surg Oncol. 2018;118. https://doi.org/10.1002/jso.25155 .
Lee S, Seong D, Yoon J, Lee S, Baac HW, Lee D, et al. A skin-conformal, stretchable, and breathable fiducial marker patch for surgical navigation systems. Micromachines (Basel). 2020;11. https://doi.org/10.3390/mi11020194 .
Marichal DA, Barnett DW, Meler JD, Layton KF. Fiducial marker placement for intraoperative spine localization. J Vasc Interv Radiol. 2011;22. https://doi.org/10.1016/j.jvir.2010.09.017 .
Imaizumi A, Araki T, Okada H, Sasaki Y, Komiyama T, Suzuki T et al. Transarterial fiducial marker implantation for CyberKnife radiotherapy to treat Pancreatic cancer: an experience with 14 cases. Japanese J Radiol 2021;39. https://doi.org/10.1007/s11604-020-01040-1 .
Ayres FJ, Zuffo MK, Rangayyan RM, Boag GS, Filho VO, Valente M. Estimation of the tissue composition of the tumour mass in neuroblastoma using segmented CT images. Med Biol Eng Comput. 2004;42:366–77. https://doi.org/10.1007/BF02344713 .
doi: 10.1007/BF02344713
pubmed: 15191083
Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol. 2003;14. https://doi.org/10.1097/01.rvi.0000094584.83406.3e . :S199-202.
Fiore M, MacNeill A, Gronchi A, Colombo C. Desmoid-type fibromatosis: Evolving Treatment standards. Surg Oncol Clin N Am. 2016;25:803–26. https://doi.org/10.1016/j.soc.2016.05.010 .
doi: 10.1016/j.soc.2016.05.010
pubmed: 27591500
Nuyttens JJ, Rust PF, Thomas CRJ, Turrisi AT 3rd. Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: a comparative review of 22 articles. Cancer. 2000;88:1517–23.
doi: 10.1002/(SICI)1097-0142(20000401)88:7<1517::AID-CNCR3>3.0.CO;2-9
pubmed: 10738207
Vora BMK, Munk PL, Somasundaram N, Ouellette HA, Mallinson PI, Sheikh A, et al. Cryotherapy in extra-abdominal desmoid tumors: a systematic review and metaanalysis. PLoS ONE. 2021;16. https://doi.org/10.1371/journal.pone.0261657 .
Havez M, Lippa N, Al-Ammari S, Kind M, Stoeckle E, Italiano A, et al. Percutaneous image-guided cryoablation in inoperable extra-abdominal desmoid tumors: a study of tolerability and efficacy. Cardiovasc Intervent Radiol. 2014;37:1500–6. https://doi.org/10.1007/s00270-013-0830-9 .
doi: 10.1007/s00270-013-0830-9
pubmed: 24402645
Gondim Teixeira PA, Biouichi H, Abou Arab W, Rios M, Sirveaux F, Hossu G, et al. Evidence-based MR imaging follow-up strategy for desmoid-type fibromatosis. Eur Radiol. 2020;30:895–902. https://doi.org/10.1007/s00330-019-06404-4 .
doi: 10.1007/s00330-019-06404-4
pubmed: 31468156
Schmitz JJ, Schmit GD, Atwell TD, Callstrom MR, Kurup AN, Weisbrod AJ, et al. Percutaneous cryoablation of Extraabdominal Desmoid tumors: a 10-Year experience. AJR Am J Roentgenol. 2016;207:190–5. https://doi.org/10.2214/AJR.15.14391 .
doi: 10.2214/AJR.15.14391
pubmed: 27064168
Auloge P, Garnon J, Robinson JM, Thenint MA, Koch G, Caudrelier J et al. Percutaneous cryoablation for advanced and refractory extra-abdominal desmoid tumors. Int J Clin Oncol 2021;26. https://doi.org/10.1007/s10147-021-01887-y .
Atzmon R, Amar E, Maor D, Rath E. A combined endoscopic and open surgical approach for chronic retracted proximal hamstring avulsion. J Hip Preserv Surg. 2019;6:284–8. https://doi.org/10.1093/jhps/hnz037 .
doi: 10.1093/jhps/hnz037
pubmed: 31798931
pmcid: 6874769